Experienced in Age-Related Macular Degeneration (ARMD)

Ingeborg Stalmans

Leuven, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Age-Related Macular Degeneration (ARMD)
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Ingeborg Stalmans practices in Leuven, Belgium. Ms. Stalmans is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy.

Her clinical research consists of co-authoring 187 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles and participated in 1 clinical trial in the study of Age-Related Macular Degeneration (ARMD).

Gender
Female

Locations

Leuven, VLG, Belgium
Other Locations
Heverlee, VLG 3001, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
Enrollment Status: Recruiting
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drugs: Preservative Free Drop Treatment, Preserved Drop Treatment
Study Phase: Phase 4
Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients
Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients
Enrollment Status: Completed
Publish Date: July 16, 2024
Intervention Type: Drug
Study Drug: Timolol & Dorzolamide
Study Phase: Phase 4
View 1 Less Clinical Trial

187 Total Publications

GONet: A Generalizable Deep Learning Model for Glaucoma Detection.
GONet: A Generalizable Deep Learning Model for Glaucoma Detection.
Journal: IEEE transactions on bio-medical engineering
Published: June 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Stalmans's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile